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Abstract
Extracellular vesicles (EVs) from osteoclasts are important regulators in intercellular com-
munication. Here, we investigated the proteome of EVs from clastic cells plated on plastic
(clasts), bone (osteoclasts) and dentin (odontoclasts) by two-dimensional high performance
liquid chromatography mass spectrometry seeking differences attributable to distinct miner-
alized matrices. A total of 1,952 proteins were identified. Of the 500 most abundant proteins
in EVs, osteoclast and odontoclast EVs were 83.3% identical, while clasts shared 70.7% of
the proteins with osteoclasts and 74.2% of proteins with odontoclasts. For each protein, the
differences between the total ion count values were mapped to an expression ratio histo-
gram (Z-score) in order to detect proteins differentially expressed. Stabilin-1 and macro-
phage mannose receptor-1 were significantly-enriched in EVs from odontoclasts compared
with osteoclasts (Z = 2.45, Z = 3.34) and clasts (Z = 13.86, Z = 1.81) and were abundant in
odontoclast EVs. Numerous less abundant proteins were differentially-enriched. Subunits of
known protein complexes were abundant in clastic EVs, and were present at levels consis-
tent with them being in assembled protein complexes. These included the proteasome,
COP1, COP9, the T complex and a novel sub-complex of vacuolar H+-ATPase (V-ATPase),
which included the (pro) renin receptor. The (pro) renin receptor was immunoprecipitated
using an anti-E-subunit antibody from detergent-solubilized EVs, supporting the idea that
the V-ATPase subunits present were in the same protein complex. We conclude that the
protein composition of EVs released by clastic cells changes based on the substrate. Clastic
EVs are enriched in various protein complexes including a previously undescribed V-
ATPase sub-complex.
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Introduction
Extracellular vesicles (EVs) released by osteoclasts are important regulators of bone remodel-
ing [1–4]. RANK-containing EVs from osteoclasts regulate osteoclastogenesis by a paracrine
mechanism [1]. Very recently, RANK-containing EVs released by osteoclasts were found to
bind osteoblasts through RANKL [4;5]. This binding stimulated RANKL reverse signaling in
osteoblasts through the Runt-related transcription factor 2 (Runx2) pathway. This led to
increased osteoblast differentiation in vitro and increased bone formation in vivo. It was postu-
lated that RANK-containing EVs released by osteoclasts are vital for coupling bone resorption
with bone formation [4].
We recently showed by low resolution one-dimensional mass spectrometry that there are
differences in the protein composition of EVs released by osteoclasts (clastic cells resorbing
bone) and odontoclasts (clastic cells resorbing dentin) [6]. Clastic cells are multinuclear cells
responsible for the physiological and pathological breakdown of mineralized tissues, including
bone and tooth dentin. While the consensus on the nomenclature for these ‘clastic’ cell types is
still evolving, some authors propose to name them based on the matrix that they resorb [7–
10]. Osteoclasts and odontoclasts are thought to differentiate from the same hematopoietic
stem cells, but little is known about the timing and mechanism of their differentiation [7]. Key
differences in odontoclastic and osteoclastic activity have been reported. Odontoclasts are not
regulated by parathyroid hormone (PTH) as are osteoclasts [11]. Moreover, odontoclasts show
higher activity in forming resorption lacunae, and interleukin-1 (IL-1) stimulates the forma-
tion of resorption lacunae on dentin to a higher extent than bone [12]. Therefore, under spe-
cific circumstances, osteoclasts and odontoclasts may behave and function differently.
EVs are 30–150 nm in diameter [13]. They include exosomes, which are derived from mul-
tivesicular bodies, and microvesicles, which bud directly from the plasma membrane [13]. EVs
carry proteins, lipids, metabolites and ribonucleic acids (RNAs), and can transmit these ele-
ments to target cells. They play key roles in intercellular communication and signaling and
they show promise as biomarkers and as vehicles for drug delivery [13–15]. EVs are present in
most biological fluids, including blood, urine, saliva, mucus, breast milk, bile, and gingival cre-
vicular fluid [14,16,17].
To gain greater insight into the composition of EVs from clastic cells, we performed two-
dimensional high performance liquid chromatography mass spectrometry (2D HPLC-MS/
MS) on EVs from clasts on plastic, odontoclasts and osteoclasts. Our data confirm that the sub-
strate regulates the protein composition of the EVs released by clastic cells. We find evidence
for numerous protein complexes, including a novel V-ATPase sub-complex, which make up a
large component of the total protein composition of clastic EVs. Differences in the protein
composition of osteoclasts and odontoclasts that are identified provide a basis for studying the
regulatory mechanisms of clastic EVs and identify potential biomarkers for pathological dental
root resorption and other oral diseases.
Materials and methods
Experimental design and cell culture protocol
The use of animals for this study was approved by the University of Florida Institutional Care
and Use Committee (IACUC, protocol number: 201207596) and carried out in accordance
with the recommendations in the guide for care and use of laboratory animals of the National
Institutes of Health. No procedure involving pain or suffering were performed on the mice
prior to their sacrifice. Briefly, clastic cells were grown as described in detail in previous publi-
cations [1,6]. Precursors were isolated from the bone marrow of femur and tibiae of 4 to 6
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week-old wild type C57Bl/6 mice by flushing with alpha-MEM (2.5 ml/bone) using a 10-ml
syringe and 25-gauge needle. The mononuclear cells were then plated at a density of 0.5 x 106
cells/well on bone slices, dentin discs or empty plastic tissue culture wells (Fig 1A) and cultured
for seven days with 10% EV-depleted fetal bovine serum (Exo-FBS, System Biosciences). To
induce osteoclastogenesis, mononuclear cells were supplemented with recombinant mouse
M-CSF (20 ng/ml; R&D Sys.) and recombinant soluble mouse RANKL (20 ng/ml; R&D Sys.).
Medium was changed twice after the viability of the cells was confirmed by visual inspection
using a light microscope. At the end of the cell culture period, clastic cell formation was
assessed by staining for tartrate-resistant acid phosphatase (TRAP) using a leukocyte phospha-
tase kit (Sigma-Aldrich) as per the manufacturer’s instruction [18]. Resorption status was
determined by using actin ring-formation as a surrogate marker for bone resorption as previ-
ously described [19]. Experiments were performed in triplicate to reduce random error and
experimental bias.
EV isolation and quantitation
EVs were isolated as described previously [1,6]. Cell conditioned media from culture period
Days 4–7 was removed from the wells, pooled in sterile 15 ml conical tubes and centrifuged
Fig 1. Generation of osteoclasts, odontoclasts and clasts in cell culture. Presence of tartrate-resistant acid phosphatase (TRAP) positive cells at the
end of the cell culture period on (A) osteoclasts on bone slice; (B) odontoclasts on dentin slice; (C) clasts on plastic tissue culture plate. All photos are
at the same magnification. Note that on plastic some giant cells with more than 10 nuclei form whereas on bone or dentin rarely are cells with more
than 5 nuclei detected. To confirm that osteoclasts (D) and odontoclasts (E) were resorbing, actin rings, which are surrogate markers for resorbing
osteoclasts and odontoclasts, were stained with rhodamine-phalloidin. The scale bar is 66 μm in A-C and 12 μm in D and E.
https://doi.org/10.1371/journal.pone.0219602.g001
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at 3,000g for 30 minutes at room temperature. The supernatant was transferred to new
tubes and ExoQuick TC solution (System Biosciences) was added to the media at a ratio of
1:5. The samples were incubated overnight at 4˚C then centrifuged at 1,500g for 30 minutes
to remove the supernatant. The pellets were resuspended in 150 μl PBS, subjected to ultra-
centrifugation at 100 K x g using in an Airfuge (Beckman), and the pellets were frozen at
-80˚C for future analyses. EVs were quantified in 10 μL of the resuspended pellet by measur-
ing the enzymatic activity of acetecylcholinesterase (AChE) using the EXOCET Quantita-
tion kit (System Bioscience) per the manufacturer’s instructions. We have found that the
estimates of EV numbers obtained by EXOCET agreed closely with numbers obtained by
nanoparticle tracking using a NanoSight NS300 (Malvern).
Proteomics profiling
EVs from osteoclasts, odontoclasts and non-resorbing clastic cells (cells on plastic) were
pooled across three rounds of experiments for two dimensional high performance liquid
chromatography-mass spectrometry analysis (2D HPLC-MS/MS). The isolated EVs were
solubilized in 1 M urea/0.2 M Tris/HCl buffer pH 7.6, and the proteins digested with trypsin
using the Filter Aided Sample Preparation (FASP) technique [20]. Resulting digests were
acidified with trifluoroacetic acid (TFA) and purified by reversed-phase solid-phase extrac-
tion. Each sample contained 5–10 μg of digested EV proteins as determined by Nanodrop
2000 (Thermo Fisher Scientific, Rockford IL). The 2D HPLC-MS/MS analysis of the EV
extracts was performed as described in detail previously [21]. Agilent 1100 series LC system
with UV detector (214 nm) and 1mm×100mm XTerra C18, 5 μm column (Waters, Ireland)
was used for pH 10 first dimension reversed-phase separation [21]. 1.25% acetonitrile per
minute gradient (0–40% acetonitrile in 32 min) was delivered at 150 μL/min flow rate. Both
eluents A (water) and B (1:9 water:acetonitrile) contained 20 mM ammonium formate pH
10. Thirty 1-min fractions were collected and concatenated into 10 to provide optimal sepa-
ration orthogonality [21]. Second dimension LC-MS/MS has been performed using a nano
LC-MS system coupled to a Triple TOF 5600 mass spectrometer (ABSciex, Toronto,
Ontario, Canada), via an IonSpray III nano-source (ABSciex). A splitless nano-flow 2D LC
Ultra system (Eksigent, Dublin, CA) was used to deliver water/acetonitrile gradient at 500
nL/min flow rate through a 100μm×200mm analytical column packed with 3μm Luna C18
(2) (Phenomenex, Torrance, CA). Sample injection for individual fractions via a
300μm×5mm PepMap100 trap-column (Thermo Fisher Scientific) was used in all experi-
ments. The gradient program included following steps: linear increase from 0.5 to 30% of
buffer B (acetonitrile) in 78 min, 5 min columns wash with 90% B and 8 min system equili-
bration using starting conditions of 0.5% B (0.38% acetonitrile per minute gradient, 90 min
total run time). Both eluents A (water) and B (acetonitrile) contained 0.1% formic acid as
ion-pairing modifier. Each Triple TOF 5600’s measurement cycle consisted of a 250-ms MS
measurement (m/z values of eluting peptides) and up to 20 MS/MS (100 ms each) per-
formed on the most abundant peaks. Ten individual concatenated fractions from the first
separation dimensions were analyzed for each sample. The resulting 10 mascot generic for-
mat (MGF) spectra files were sequentially concatenated into a single file for peptide identifi-
cation and quantitation, which was conducted in-house at the Manitoba Center for
Proteomics (Winnipeg MB, Canada) using X!Tandem search algorithm and additional
retention time prediction filtering [22,23] with 20 parts per million (ppm) and 50 ppm mass
tolerance for parent and fragment ions, respectively. Additional X!Tandem parameters
included: oxidation of Met, Trp; N-terminal cyclization at Gln, Qln, Cys; N-terminal acety-
lation, phosphorylation (Ser, Thr, Tyr); deamidation (Asn and Gln); an expectation value
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cut-off of log(e)<−1 for both proteins and peptides. Identified single-missed-cleavage tryp-
tic peptides from the Mus musculus Uniprot database (16,704 proteins) were quantified
using the sum of their MS2 fragment intensities.
Statistical and data analysis of mass spectrometry results
Each protein quantitation entry was the log2 transform of the sum of the intensities of its
member peptides, with a rule of a peptide minimum expectation value log(e)< = -1.5 each,
and at least two non-redundant peptides per protein required for quantitation. Protein-
level differences between samples were then mapped into Z-scores, i.e. the distance from
the population mean in units of standard deviation. Z-scores were calculated for three pair-
wise comparisons as follows: 1) odontoclasts versus non-resorbing clasts, 2) osteoclasts ver-
sus non-resorbing clasts, and 3) osteoclasts versus odontoclasts. Each comparison gave a
three-mode population, with proteins quantified in one state but not the other forming the
negative and positive outer sets respectively, and proteins quantified in both states forming
the central population. The mean and standard deviation of this central population was
computed and used to transform the entire set on a protein-by-protein level into Z-scores
using the equation: Z-score = (Z—mean) / SD. Proteins with Z-scores greater than 1.65 or
smaller than -1.65 (the outermost 10% of the distribution) were considered significantly
higher or lower in one EV sample versus another.
Detection of protein complexes
Inspection of the proteomic data revealed that subunits of stable protein complexes with spe-
cific stoichiometry were abundant in samples. These appeared in similar ratio’s that were con-
sistent in various samples. To better understand these complexes, we plotted them based on
the molecular weight of the components and expected stoichiometry of the complex versus
their relative abundance in EVs estimated as described above.
Immunoprecipitation of V-ATPase sub-complex
High affinity protein A-agarose (Abcam) was incubated with rabbit antisera anti-E
V-ATPase subunit. The antibody was crosslinked to protein A-agarose using DMP (Sigma)
as we have described [24]. EVs from three-day conditioned media from one 100 cm tissue
culture plate were homogenized in 200–500 μl solubilization buffer (SB; 20 mM Tris/HCl
pH 7.4, 5 mM Sodium Azide, 1 mM EDTA, 1 mM dithiothreitol, 1.5% n-octyl β glucopyr-
annoside, 0.6% CHAPS, 10% glycerol plus PMSF, and a cocktail of addition protease inhibi-
tors). EVs were then homogenized by 15 passes in a 1 ml, tight fitting, glass homogenizer.
Samples were incubated with 15 μl of the antibody conjugated protein A beads for 2 hours
at 4 degrees Celsius, then washed 3X in 0.5 ml ice cold NET-gel buffer (50 mMTris/HCl pH
7.4, 150 mM NaCl, 0.1% Nonidet P-40, 1 mM EDTA, 0.25% gelatin, 5 mM NaAzide). The
beads were then resuspended in 30 μl SDS-PAGE sample buffer, heated to 95 degrees Cel-
sius, and the soluble material was separated by SDS-PAGE, blotted to nitrocellulose and
probed with anti-PRR antibody (AbCam).
Use of proteomic data tools
Gene ontology and biological process enrichment analysis of the EV proteins that were
uniquely found in one matrix versus the other was carried out using FunRich (www.funrich.
org), an open access functional enrichment analysis tool.
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Results
EV preparation from clasts, osteoclasts and odontoclasts
Clastic cells precursors were differentiated on plastic (clasts), bone (osteoclasts), and dentin
(odontoclasts). Multinuclear TRAP positive, clasts, osteoclasts and odontoclasts were detected
after 7 Days (Fig 1A–1C). The resorbing activity of odontoclasts and osteoclasts was confirmed
by staining cells with phalloidin to detect the distinctive actin ring structures that are charac-
teristic of resorbing clastic cells (Fig 1D and 1E). EVs were isolated from conditioned media
from clasts, osteoclasts and odontoclasts and EV numbers were determined by EXOCET
quantitation (Systems Biosciences). Clasts produced the highest average number of EVs/well
(9.72 x 109), followed by osteoclasts (7.296 x 109) and odontoclasts (5 x 109).
Mass Spectrometry analysis identified 1,952 proteins with log(e) scores<−10 and the pres-
ence of at least two peptides in the isolated EVs (S1 Table). Eight-four percent of these proteins
(1640) were found in the ExoCarta database [25] confirming that there was an enrichment of
exosomal proteins in our samples. Abundant proteins were even more likely to be found in Exo-
Carta. For example, of the 100 most abundant proteins in osteoclast EVs, 95 were in ExoCarta
and two not found, TRAP type 5A and cathepsin K, are markers for clastic cells. A total of 102
proteins were found only in odontoclast EVs, whereas 524 unique proteins were identified in the
EVs from osteoclasts. There was an overlap of 425 proteins between osteoclasts and odontoclasts,
while 712 proteins were common among EVs from all clastic cells (Fig 2A). As a first approxima-
tion of the nature of the proteins detected, we sorted them into functional categories using Fun-
Rich (Fig 2B). Only four biological process categories were represented by 10% or more of the
total proteins and there was little variation in the biological processes between EVs from different
source cell-types. Proteins in EVs displayed a range of cellular locations, but there were no obvi-
ous differences between groups (Fig 2C). Comparing the 100 and 500 most abundant proteins
found in each type of EV, osteoclasts and odontoclasts shared 79% and 83.3% of proteins, osteo-
clasts and clasts shared 71% and 70.7% and odontoclasts and clasts shared 74% and 74.2%.
Statistical comparison of data sets
Pairwise comparisons at day 7 of the cell culture (osteoclasts vs. odontoclasts, osteoclasts vs.
non-resorbing clasts, and odontoclasts vs. non-resorbing clasts) identified numerous proteins
that were significantly enriched (Z > 1.65) and identified by at least 2 peptides in EVs from
specific sources (S2 Table). Many of these were low abundance proteins that were identified by
only 2 or 3 peptides. To better understand the proteins in EVs, we examined the nature and
cellular location of the proteins detected.
Proteins are extracellular, transmembrane or cytosolic. We categorized the 200 most abun-
dant proteins from clasts, osteoclasts and odontoclasts. Cytosolic proteins were most numer-
ous, followed by extracellular proteins, and only a few transmembrane proteins were detected
(Fig 3). There was also more variance among the samples with regard to abundant transmem-
brane proteins compared with cytosolic or extracellular proteins. Recent developments in sort-
ing, isolating and characterizing EVs make transmembrane proteins attractive to use to detect
and differentially isolate EVs [26]. We therefore focused on transmembrane proteins
(Table 1). Our dataset from clastic cells was compared with published EV datasets from other
cell types. These included human monocyte-derived macrophages (Mac), U87 glioblastoma
cells (U87), Huh7 hepatocellular carcinoma cells (Huh7) and human bone marrow-derived
mesenchymal stem cells (MSC) [27,28]. The presence of other cell types in parenthesis in the
gene symbol column (Table 1) indicate that these proteins have been previously reported in
EVs released by the indicated cell types.
The proteome of extracellular vesicles released by clastic cells
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RANK may be both a component of biologically-active EVs and an EV-marker for diseases
[1,4,29]. RANK was detected at low levels in clasts and slightly higher levels in osteoclasts, but
was not detected in odontoclasts EVs (Table 1). Immunoblots confirmed that the level of
RANK was reduced in EVs from odontoclasts. The level of RANK in the total cells extracts,
however, was similar, suggesting that a mechanism to load RANK into EVs is repressed in
odontoclasts compared to clasts and osteoclasts (Fig 4). Stabilin-1 was significantly more abun-
dant in odontoclast EVs than osteoclast EVs (Z = - 2.45) and it was not detected in clasts
(Z = 13.86). It therefore represents a promising potential biomarker for odontoclasts (Table 1).
Macrophage mannose receptor-1 was somewhat less abundant, but was also significantly
enriched in odontoclast EVs compared with osteoclast EVs (Z = - 3.34) and clasts (1.81)
(Table 1).
Fig 2. Overview of protein composition of EVs from clastic cells. (A) Venn diagram of proteins detected from osteoclasts,
odontoclasts and clasts. (B) Comparison of the gene ontology biological pathways represented by 10% or more of the total
proteins in EVs. (C) Selected primary cellular location of proteins detected in clastic EVs. These locations were abundant and
indicative of the general feature that there was little difference between the groups of clastic EVs.
https://doi.org/10.1371/journal.pone.0219602.g002
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We further examined various classes of transmembrane proteins. Cluster of differentiation
(CD)81 and CD109 were found at relatively high levels in EVs from osteoclasts and odonto-
clasts and at low levels or not detected in clasts. CD36 was detected in odontoclasts, but not
osteoclasts or clasts, making it another potential biomarker for root resorption in spite of its
low abundance (Table 1). An abundant integrin detected in clastic EVs was alpha-M beta2.
Three potential alpha partners, alpha 2, alpha 4 and alpha 5, for integrin Beta1 were found in
clastic EVs. Only one potential partner for integrin Beta 3, alphaV, was detected at significantly
higher levels (Z = 1.91) in EVs from osteoclasts compared with either odontoclasts or clasts
(Table 1).
Comparison of clastic cells with other cell types
Clastic cells are highly specialized to function on mineralized tissues. Thus, we wanted to com-
pare the proteomic profile of clastic cells EVs to recently reported proteomic datasets of EVs
from other cell types including human monocyte-derived macrophages (Mac), U87 glioblas-
toma cells (U87), Huh7 hepatocellular carcinoma cells (Huh7) and human bone marrow-
derived mesenchymal stem cells (MSC) [27,28]. Some abundant complexes found in clastic
EVs, such as the Arp2/3 complex, proteasome, COP1, COP9 and the T complex, were also
present in EVs released by other cell types (Table 2). Unlike other V-ATPase elements, the iso-
forms of the a-subunit were not detected in clastic EVs. In contrast, the (pro) renin receptor
(PRR), which was abundant in clastic EVs, was either not detected or was at very low levels in
EVs from Mac, U87, Huh7 and MSC (Tables 1 and 2). Stabilin-1 was not detected in EVs from
the cell types surveyed by previous authors, while macrophage mannose receptor-1 was
detected in EVs from macrophages (Table 1). RANK was not detected in EVs from other
sources (Table 1).
Protein complexes in clastic EVs
We detected elements of numerous stable protein complexes in clastic EVs. These included
the actin-related 2/3 (Arp2/3) complex [30], the proteasome [31–33], the coatamer protein
(COP) 1 complex [34], the T complex, the COP9 complex [35], and many, but not all subunits
Fig 3. Categorization of proteins by cellular location. The 200 most abundant proteins in extracellular vesicles (EVs)
were categorized based on their expected cellular location. Numbers at the top indicate the percentage of the proteins
in the category reported to be extracellular vesicle (EV) proteins in ExoCarta. EVs from all types of clastic cells had
mostly cytosolic proteins and very few transmembrane proteins.
https://doi.org/10.1371/journal.pone.0219602.g003
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13 16 9 0.21 0.43 0.33
Q60754 MARCO (Mac) Macrophage receptor
MARCO
6 5 - 13.99 11.58 -1.09
P43406 ITGAV (Huh7,
MSC, U87, Mac)
Integrin alpha-V 13 36 20 -1.12 0.32 1.91
Q61207 PSAP (U87, Mac) Prosaposin 20 22 8 1.61 0.69 -1.09
A2A8L5 PTPRF (Huh7) Receptor-type tyrosine-
protein phosphatase F
26 24 25 -0.93 -1.48 -1.02
Q2PZL6 FAT4 Protocadherin Fat 4 17 16 21 -0.99 -1.07 -0.32





11 11 9 0.12 -0.02 -0.22
Q8R4Y4 STAB1 Stabilin-1 63 38 - 13.86 10.54 -2.45
Q61830 MRC1 (Mac) Macrophage mannose
receptor 1
41 15 8 1.81 -0.65 -3.34
P05555 ITGAM (Mac) Integrin alpha-M 20 19 11 0.6 0.31 -0.36
Q62465 VAT1 (U87, Mac) Synaptic vesicle
membrane protein VAT-
1 homolog
11 12 3 1.13 0.51 -0.74
P35762 CD81 (Huh7,
MSC, U87, Mac)
CD81 antigen 3 3 2 1.76 -0.05 -2.4
Q8R422 CD109 (U87,
Mac)
CD109 antigen 4 29 - 9.98 11 3.26
Q08857 CD36 (MSC) Platelet glycoprotein 4 2 - - 9.89 - -14.99
P40240 CD9 (Huh7,
MSC, U87, Mac)
CD9 antigen 2 2 2 1.41 0.7 -0.84
P40237 CD82 (U87, Mac) CD82 antigen 3 3 - 10.63 9.8 0.64
P15379 CD44 (U87, Mac) CD44 antigen 4 5 4 -0.86 -0.01 1.07
O35305 TNFRSF11A RANK - 4 2 -10.71 -0.39 13.31
Q00651 ITGA4 Integrin alpha-4 4 3 - 9.96 7.56 -
P11688 ITGA5 (Huh7,
MSC, U87, Mac)
Integrin alpha-5 - 2 - - 7.34 12.15
Q62469 ITGA2 (Huh7,
MSC, U87, Mac)
Integrin alpha-2 - 9 2 -12.14 -0.66 14.76
P09055 ITGB1 (Huh7,
MSC, U87, Mac)
Integrin beta-1 11 11 10 -0.32 -1.01 -1.11
O54890 ITGB3 (Huh7,
MSC, U87, Mac)
Integrin beta-3 7 20 9 -0.84 0.43 1.7
Q8BNA6 FAT3 Protocadherin Fat 3 4 - 3 -0.03 -10.27 -15.18
(Continued)
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Q5F226 FAT2 Protocadherin Fat 2 - - 2 -12.24 -11.27 -
�Parentheses after gene symbol indicates cell types where found: human monocyte-derived macrophages (Mac), U87 glioblastoma cells (U87), Huh7 hepatocellular
carcinoma cells (Huh7) and human bone marrow-derived mesenchymal stem cells (MSC). Data from Huh7, MSC, U87 and Mac come from references [27,28].
A negative Z-score means that the protein was more abundant in extracellular vesicles from the second cell type in each pairwise comparison (Odontoclasts vs. Clasts,
Osteoclasts vs. Clasts, Osteoclasts vs. Odontoclasts).
https://doi.org/10.1371/journal.pone.0219602.t001
Fig 4. Immunoblot confirms that reduced levels of RANK are present in EVs from odontoclasts. Left panel; 3 X 107 EVs
(by nanoparticle tracking) isolated from clasts, odontoclasts and osteoclast were separated by SDS-PAGE, blotted to
Immobilon P, and probed with anti-RANK antibody (Biorbyt, Cat # orb8560). Note the reduced level of RANK in the EVs
from odontoclasts. Middle panel; 100 μg of protein from whole cell extracts of clasts, odontoclasts and osteoclasts was probed
with the anti-RANK antibody. Levels of RANK were similar in all cell types. Right panel; The same cell extracts from clasts,
odontoclasts and osteoclasts were probed with anti-actin (Sigma, Cat # A2066) to show that the loading of proteins was
similar.
https://doi.org/10.1371/journal.pone.0219602.g004
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of the V-ATPase [36] (Tables 2 and S3). We also identified sets of proteins that are known to
interact with each other transiently, including numerous proteins known to associate with the
cytoskeleton at focal adhesions [37] and podosomes [38] and abundant glycolytic enzymes,
which form complexes [39].
To determine the accuracy of the quantitative assessment of proteins we examined alpha
and beta hexosaminadase. The two subunits form a stable dimer and the two proteins are simi-
lar in size. Assuming they enter EVs as a dimer, it would be expected that they would have sim-
ilar abundance. As shown in Fig 5A, in six independent groups, the relative detected levels of
alpha and beta hexosaminadase were very similar.
Several abundant complexes in clastic cell EVs with known protein sizes and stoichiometry
were plotted by abundance, based on area under the slope of their peptides, against their
Table 2. Protein complexes found in clastic cells and other cell types.
Coatamer protein 1
(COP1)
T-Complex 20S Proteasome alpha
subunits


















CCT2 (Huh7, MSC, U87, Mac)
CCT8 (Huh7, MSC, U87, Mac)
CCT4 (Huh7, MSC, U87, Mac)
CCT6A (Huh7, MSC, U87, Mac)
CCT7 (Huh7, MSC, U87, Mac)
CCT5 (Huh7, MSC, U87, Mac)
CCT3 (Huh7, MSC, U87, Mac)
TCP1 (Huh7, MSC, U87, Mac)
psma2 (Huh7, MSC, U87,
Mac)
psma6 (Huh7, MSC, U87,
Mac)
psma4 (Huh7, MSC, U87,
Mac)
psma3 (Huh7, MSC, U87,
Mac)
psma1 (Huh7, MSC, U87,
Mac)
psma7 (Huh7, MSC, U87,
Mac)
psma5 (Huh7, MSC, U87,
Mac)
psmb2 (Huh7, MSC, U87, Mac)
psmb3 (Huh7, MSC, U87, Mac)
psmb4 (Huh7, MSC, U87, Mac)
psmb1 (Huh7, MSC, U87, Mac)
psmb5 (Huh7, MSC, U87, Mac)
psmb7 (MSC, U87)
psmb6 (Huh7, MSC, U87, Mac)
psmc6 (Huh7, MSC, U87,
Mac)
psmc5 (Huh7, MSC, U87,
Mac)
psmc2 (Huh7, MSC, U87,
Mac)
psmc3 (Huh7, MSC, U87,
Mac)
psmc1 (Huh7, MSC, U87,
Mac)
psmc4 (Huh7, MSC, U87,
Mac)
V-ATPase 26S proteasome non-ATPase
regulatory subunit
V-ATPase subunits not
found in clastic cells
26S proteasome non-ATPase regulatory
subunit not found in clastic cells
Arp2/3 complex




E (Huh7, MSC, U87,
Mac)
H (Huh7, MSC, U87)
AC45 (Mac)











psmd10 (MSC, U87, Mac)
psmd14 (Huh7, MSC, U87,
Mac)
psmd7 (Huh7, MSC, U87, Mac)
psmd13 (Huh7, MSC, U87,
Mac)
psmd6 (Huh7, MSC, U87, Mac)
psmd11 (Huh7, MSC, U87,
Mac)
psmd8 (Huh7, MSC, U87, Mac)
psmd12 (Huh7, MSC, U87,
Mac)
psmd5 (Huh7, MSC, U87, Mac)
psmd3 (Huh7, MSC, U87, Mac)
psmd2 (Huh7, MSC, U87, Mac)
psmd1 (Huh7, MSC, U87, Mac)
a1 (Huh7, MSC, U87, Mac)
c (Mac)
psmd4 (Huh7, MSC, U87, Mac)
psmd9 (U87)
arp3 (Huh7, MSC, U87,
Mac)
arp2 (Huh7, MSC, U87,
Mac)
p41 (Huh7, MSC, U87,
Mac)
p34 (Huh7, MSC, U87,
Mac)
p21 (Huh7, MSC, U87,
Mac)
p20 (Huh7, MSC, U87,
Mac)
p19 (Huh7, MSC, U87,
Mac)
Parentheses after gene symbol indicates cell types where found: human monocyte-derived macrophages (Mac), U87 glioblastoma cells (U87), Huh7 hepatocellular
carcinoma cells (Huh7) and human bone marrow-derived mesenchymal stem cells (MSC). Gene symbol in normal font indicates it is present in clasts, osteoclasts and
odontoclasts. Gene symbol in bold indicates it is found in osteoclast and odontoclasts, but not clasts. Gene symbol underlined means it is found only in osteoclasts. Data
from Huh7, MSC, U87 and Mac come from references [27,28].
https://doi.org/10.1371/journal.pone.0219602.t002
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Fig 5. Evidence for protein complexes in clastic EVs. (A) Comparison of the relative abundance by 2D LC/MS/MS of hexaminidase
alpha and beta, which are known to exist as a tight dimer across 6 experiments. (B-H) Various complexes found in clastic EVs, with
relative abundance plotted against the expected amount of protein (molecular weight X expected stoichiometry). Note that the relative
abundance estimate stays similar within all elements of a complex in a group; in most cases all elements of a complex in one group are
similarly enriched or reduced compared to the other groups.
https://doi.org/10.1371/journal.pone.0219602.g005
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molecular weight and expected stoichiometry (Fig 5B–5F). These data showed that the levels
of proteins found in EVs was reasonably consistent with the levels predicted if they were ele-
ments of known protein complexes. These data also show that the relative level of the proteins
in complexes varied coordinately between samples.
A novel V-ATPase sub-complex is enriched in EVs from clastic cells
We focused attention on the V-ATPase subunits since they are very abundant in clastic cells
compared with other cell types [40] and are vital for bone resorption [41]. As expected,
V-ATPase subunits were among the most abundant elements of EVs from clastic cells (S3
Table). V-ATPases are rotary motors composed of 13 subunits: 8 peripheral proteins that
make up the V1 complex, 3 integral proteins (a, b, and c) that form the proton pump channel
[27], and 2 peripheral proteins (d and e). In addition, there are two accessory proteins, the
(pro) renin receptor (PRR) [38] and AC45[39]. We detected all of the peripheral subunits of
the V1 complex. These included the A-, B2-, C-, D-, E-, F-, G- and H-subunits. We also
detected both isoforms of the d-subunit, d1 and d2. We did not detect the a-, b- or c-subunits
that make up the proton channel. The PRR was very abundant, and we detected low levels of
AC45 (S3 Table). The Z scores for the most abundant subunits were not significant between
clastic groups (S2 Table). As with the other potential complexes, the relative expression pattern
was similar in all samples (Fig 6A).
The B-subunit and C-subunit bind microfilaments [42–44], a possible means by which the
peripheral V-ATPase subunits could be coordinately transported into EVs. However, the
abundant PRR is a transmembrane protein that is vital to the assembly and/or function of
V-ATPases [45]. We postulated that the peripheral V-ATPase subunits and d-subunits might
be shuttled into EVs in association with the PRR. The PRR has been described in some cell
types to be associated with the V-ATPase as a low molecular weight 8–9 kD cleaved protein
[46]. The peptide coverage of PRR suggested that full length PRR is present in EVs and this
was confirmed by Western Blot (Fig 6B). To test the idea that the PRR is in complex with other
V-ATPase subunits in EVs, we solubilized EVs from clasts and immunoprecipitated using an
antibody to the E-subunit. The resulting immunoprecipitate (IP) was then separated by
SDS-PAGE, blotted, and probed with an anti-PRR antibodies. The PRR was detected in the
anti-E subunit pulldown suggesting that it was in a complex that included E-subunit (Fig 6B).
These data are consistent with the V-ATPase subunits present in EVs being in a membrane
associated V-ATPase subcomplex that includes the PRR (Fig 6C).
Discussion
In this report, we present the first high resolution 2D HPLC-MS/MS proteomic description of
EVs released by clasts, osteoclasts and odontoclasts. Our data show that the substrate influ-
ences the protein composition of the EVs released from clastic cells, which all arise from the
same hematopoietic precursors. In addition, our data suggest that not only the composition
but also the quantity of EVs produced by clastic cells is a function of the differentiation state of
the cells (resorbing vs non-resorbing) and the signal the cell is releasing from the substrate
(dentin vs bone). A caveat is that the EVs may differentially bind to bone and dentin and there-
fore substrates may differentially deplete EVs, which help explain why non-resorbing clasts on
plastic produced the highest average number of EVs. Previous studies report that RANK-con-
taining EVs are crucial in intercellular regulation and may be used as a biomarker of bone
resorption [1,4,29]. Interestingly, RANK was found in EVs from clasts and osteoclasts, but was
not detected in EVs from odontoclasts (Fig 4). Both osteoclast and odontoclasts form special-
ized resorption apparatuses, composed of actin rings and ruffled membranes. Ruffled
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PLOS ONE | https://doi.org/10.1371/journal.pone.0219602 July 10, 2019 13 / 19
membranes are packed with V-ATPases [41,47,48]. V-ATPase subunits are major components
of clastic EVs. Our findings are consistent with the results of our previous 1D analysis [6] and
Fig 6. Evidence for a PRR-containing V-ATPase sub-complex in clastic EVs. (A) Relative abundance of the V-ATPase subunits and the PRR found in clastic EVs. (B)
Left, Western blot of whole EVs stained with anti-PRR; right anti-E-subunit and IgG control immunoprecipitates (IP) from detergent-extracted EVs from clasts that
were then blotted and probed with the anti-PRR antibody. HC and LC refer to the heavy and light chains of the antibodies used in the IPs. (C) Left is a schematic
representation of the intact V-ATPase. The PRR has been positioned hypothetically in the intact enzyme. Right is a schematic of the subunits detected in osteoclast EVs
assuming they are part of a single complex.
https://doi.org/10.1371/journal.pone.0219602.g006
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provide greater proteome coverage. Stabilin-1 and macrophage mannose receptor-1 were
identified as abundant membrane proteins enriched in odontoclasts.
Overall, our proteomic data revealed that clastic EVs were enriched with proteins found in
stable protein complexes (such as V-ATPase subunits, Arp2/3 complex and proteasome) or
groups of interacting proteins (actin and actin-binding proteins [49], glycolytic enzymes [50]).
The presence of these groups of proteins in fixed ratios, which corresponded to the proteins
molecular weights and expected stoichiometry’s, could be explained by their being packaged
into EVs as elements of super molecular assemblies. This finding is consistent with results of
proteomic studies of EVs from other cell types. Indeed, a recent proteomic study of EVs from
serum also reported several of the complexes that we detected in our study [51]. Packaging
assembled protein complexes into EVs could serve as an efficient means to coordinately dis-
card unneeded complexes. EVs could also shuttle pre-assembled protein complexes from cell
to cell. A vital challenge for cells is to match protein production with the need to correctly
assemble the proteins into super molecular assemblies [52,53]. Releasing surplus protein com-
plexes in EVs to be taken up by other cells, might be of greater value than simply degrading
them. This concept is consistent with the view of Takeuchi et al. [54] who previously proposed
that EV-mediated transmission is a novel physiological mechanism to promote chaperone
protein homeostasis at the organismal level.
We focused attention on the subunits of the V-ATPase that were detected in clastic EVs.
Clastic EVs were enriched in what appears to be a sub-complex of V-ATPase subunits that
includes the PRR. This interpretation was supported indirectly by the stoichiometry and
directly by immunoprecipitation of the PRR using an antibody against the E-subunit. In con-
trast with clastic EVs, EVs from other cell types carry V-ATPase sub-complexes containing
isoforms of the a-subunit, which is absent in the clastic EVs, but little or no PRR [27,28]. Clas-
tic cells express 100-fold more V-ATPase than most other cell-types [40], and V-ATPase sub-
units were among the most abundant proteins found in clastic EVs. Since every V-ATPase
sub-complex contains 10 or more proteins, V-ATPase subunits are in aggregate among the
most abundant protein elements of EVs released by clastic cells.
In addition to being of interest as a novel V-ATPase sub-complex, and as potential bio-
markers, the presence of full length PRR in EVs raises the possibility that these EVs may stimu-
late local renin/angiotensin signaling. The PRR binds pro-renin or renin and increases its
ability to cleave angiotensinogen [55]. Recent studies indicate that bone remodeling is regu-
lated in response to the renin/angiotensin signaling pathway [56–60]. Therefore, the PRR in
EVs would be ideally located to activate (pro) renin or renin and regulate local renin/angioten-
sin signaling.
We identified an enrichment of stabilin-1 in EVs from resorbing cells, but not in EVs of
non-resorbing clasts. Stabilin-1 is a large, multi-functional, type-1, transmembrane receptor
that is found on tissue macrophages and serves as an immune regulator of inflammatory pro-
cesses [61]. Other transmembrane proteins that were significantly enriched in EVs from odon-
toclasts compared with osteoclasts or clasts were macrophage mannose receptor-1 and CD36.
As expected, we found RANK in EVs from clasts and osteoclasts [1,4,15,29]. However, it was
not detected in EVs from odontoclasts. RANK-containing EVs were recently shown to be vital
for coupling bone resorption and bone formation through reverse RANKL signaling [4].
In summary, we show that the protein composition of EVs released by osteoclasts, odonto-
clasts and non-resorbing clasts differed significantly. We conclude that the EV proteome was
different among cell types and that the variability was due to the different matrix type and the
resorbing state of the clastic cells. Due to their abundance in clastic EVs, we speculate that the
V-ATPase subunits may be useful biomarkers of clast cell activity in liquid biopsy. In addition,
we find clastic EVs to be enriched in a V-ATPase sub-complex that, to the best of our
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knowledge, has not been reported. Stabilin-1 and macrophage mannose receptor-1, abundant
transmembrane proteins, were enriched in odontoclasts. Finally, RANK, which is involved in
intercellular regulation by osteoclast EVs [1,4], was found in clastic EVs at levels consistent
with previous reports.
Supporting information
S1 Table. Proteins present in extracellular vesicles (EVs) of osteoclasts, odontoclasts and
non-resorbing clasts. Proteins and peptides are sorted by their mass spectrometry signal
intensities and number of peptide hits for identification.
(XLSX)
S2 Table. Pairwise comparisons of proteins present in extracellular vesicles (EVs) and
their respective Z-scores.
(XLSX)
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